Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
AI Zheng = Aizheng = Chinese Journal of Cancer|January 2, 2003
[Specific anti-tumor effect of immune competent cell induced by HSP-70 of HeLa cells in vitro]Cai-zhi Han, Jing-sheng Liu, Shun-jiang Xu, et al.
The Kaohsiung Journal of Medical Sciences|December 11, 2020
Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic markerHai-Jun Wang, Yong-Xiang Ma, Ai-Hua Wang, et al.
International Journal of Clinical and Experimental Pathology|January 15, 2020
Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoterTao Hou, Jin'an Ma, Chunhong Hu, et al.
Optics Express|May 5, 2019
Inverse design of multifunctional plasmonic metamaterial absorbers for infrared polarimetric imagingJunyu Li, Li Bao, Shun Jiang, et al.
Clinical Case Reports|August 29, 2025
A Case of Refractory Nephrotic Syndrome Complicated With Tuberculous Pleurisy and Literature ReviewJiang-Min Wan, Qi Luo, Ping Huang, et al.
The Science of the Total Environment|December 25, 2022
Active tailings disturb the surrounding vegetation soil fungal community: Diversity, assembly process and co-occurrence patternsHouquan Liu, Jun Yao, Bang Liu, et al.
Frontiers in Immunology|May 24, 2023
Case Report: ICIs-induced Guillain-Barré syndrome recovered from mycophenolate mofetilMengge Ding, Chao Deng, Xianling Liu, et al.
Frontiers in Global Women'S Health|October 6, 2025
Burden of gastroesophageal reflux disease among women of childbearing age, with projections to 2050: an analysis of the Global Burden of Disease study 2021Siyu Zhou, Yanping Wang, Nengyi Hou, et al.
Heliyon|February 5, 2024
Prognostic significance of pan-immune-inflammation value (PIV) in nasopharyngeal carcinoma patientsNa Zhang, Tao Hou, Sujuan Zhang, et al.
Scientific Reports|July 13, 2022
Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patientsChao Deng, Na Zhang, Shun Jiang, et al.
Pageof 10